← Back to Intel
Insider ActivityNBIX
Keswani Sanjay Chandru, Chief Medical Officer at NEUROCRINE BIOSCIENCES INC, traded $268K of NBIX
Updated Jun 6, 2026
Keswani Sanjay Chandru
Chief Medical Officer
NEUROCRINE BIOSCIENCES INC ·
$NBIX
Transaction Details
| Insider | Keswani Sanjay Chandru |
|---|---|
| Title | Chief Medical Officer |
| Company | NEUROCRINE BIOSCIENCES INC |
| Ticker | NBIX |
| Transaction Type | Tax |
| Transaction Date | 2026-06-02 |
| Shares Traded | 1,733 |
| Price Per Share | $154.84 |
| Total Value | $268K |
| Filed Date | 2026-06-04 |
| Accession Number | 0001818524-26-000004 |
Ownership Context
| Shares Owned After Transaction | 1,479 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001818524-26-000004
Other Insider Trades — NBIX
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Cooke Julie | Chief Human Resources Officer | traded | $2.0M | 2026-06-02 |
| Cooke Julie | Chief Human Resources Officer | sold | $661K | 2026-06-02 |
| Cooke Julie | Chief Human Resources Officer | sold | $558K | 2026-06-02 |
| Keswani Sanjay Chandru | Chief Medical Officer | traded | — | 2026-06-02 |
| Cooke Julie | Chief Human Resources Officer | sold | $2.2M | 2026-06-02 |
| Cooke Julie | Chief Human Resources Officer | sold | $850K | 2026-06-02 |
| Cooke Julie | Chief Human Resources Officer | sold | $1.5M | 2026-06-02 |
| Onyia Jude | Chief Scientific Officer | sold | $1.8M | 2026-06-01 |
| Onyia Jude | Chief Scientific Officer | traded | $932K | 2026-06-01 |
| Delaet Ingrid | Chief Regulatory Officer | sold | $354K | 2026-05-29 |
Other Trades by Keswani Sanjay Chandru
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| NBIX | NEUROCRINE BIOSCIENCES INC | traded | — | 2026-06-02 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for NBIX — NEUROCRINE BIOSCIENCES INC →
Track NBIX insider activity in real time on The Wire →
Get alerts when Keswani Sanjay Chandru files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 06, 2026 at 07:01 UTC